Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCDC168 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
NAB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
CAMK1G - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CAMTA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLDN - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
LOC102723757 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DEFB119 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00928 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC4A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RGR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CD24 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OPRK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on